Phenolic Compounds Isolated from Psoralea corylifolia Inhibit IL-6-induced STAT3 Activation (original) (raw)
Planta Med 2012; 78(09): 903-906
DOI: 10.1055/s-0031-1298482
Biological and Pharmacological Activity
Letters
Georg Thieme Verlag KG Stuttgart · New York
Seung Woong Lee
1Bioindustrial Process Research Center, Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Korea
Bo Ra Yun
1Bioindustrial Process Research Center, Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Korea
,
Mi Hwa Kim
1Bioindustrial Process Research Center, Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Korea
,
Chan Sun Park
1Bioindustrial Process Research Center, Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Korea
,
Woo Song Lee
1Bioindustrial Process Research Center, Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Korea
,
Hyun-Mee Oh
1Bioindustrial Process Research Center, Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Korea
,
Mun-Chual Rho
1Bioindustrial Process Research Center, Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si, Korea
Further Information
Publication History
received 01 June 2011
revised 25 March 2012
accepted 04 April 2012
Publication Date:
09 May 2012 (online)
Abstract
Inhibiting interleukin-6 (IL-6) has been postulated as an effective therapy in the pathogenesis of several inflammatory diseases. In this study, seven flavonoids were isolated from the methanol extracts of Psoralea corylifolia by bioactivity-guided fractionation. The structures of bakuchiol (1), bavachinin (2), neobavaisoflavone (3), corylifol A (4), corylin (5), isobavachalcon (6), and bavachin (7) were determined by spectroscopic analysis (1H-, 13C- NMR and MS). We demonstrated that compounds 1–7 showed an inhibitory effect on IL-6-induced STAT3 promoter activity in Hep3B cells with IC50 values of 4.57 ± 0.45, 3.02 ± 0.53, 2.77 ± 0.02, 0.81 ± 0.15, 1.37 ± 0.45, 2.45 ± 0.13, and 4.89 ± 0.05 µΜ, respectively. These compounds also inhibited STAT3 phosphorylation induced by IL-6 in Hep3B cells. Overall, several flavonoids from P. corylifolia might be useful remedies for treating inflammatory diseases by inhibiting IL-6-induced STAT3 activation and phosphorylation.
Key words
Psoralea corylifolia L. - Fabaceae - flavonoids - IL-6 - STAT3 - anti-inflammatory
References
1 Luger TA, Schwarz T, Krutmann J, Kirnbauer R, Neuner P, Kock A, Urbanski A, Borth W, Schauer E. Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells. Ann NY Acad Sci 2008; 557: 405-414
2 Neveu WA, Allard JB, Dienz O, Wargo MJ, Ciliberto G, Whittaker LA, Rincon M. IL-6 is required for airway mucus production induced by inhaled fungal allergens. J Immunol 2009; 183: 1732-1738
3 Morishima A, Marui A, Shimamoto T, Saji Y, Nishina T, Komeda M. A case of interleukin-6-producing cardiac myxoma resembling multicentric Castlemanʼs disease. J Thorac Cardiovasc Surg 2009; 138: 499-501
4 Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis: evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis 2009; 68: 1580-1584
5 Mori A, Toyoshima N, Saito M, Oka T, Irie T, Morioka M. Hypercalcemia and multiple osteolytic lesions associated with proinflammatory cytokines in a patient with acute lymphoblastic leukemia. Rinsho Ketsueki 2007; 48: 559-564
6 Fulciniti M, Hideshima T, Vermot-Desroches C, Pozzi S, Nanjappa P, Shen Z, Patel N, Smith ES, Wang W, Prabhala R, Tai YT, Tassone P, Anderson KC, Munshi NC. A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma. Clin Cancer Res 2009; 15: 7144-7152
7 Bhagat K, Valance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo . Circulation 1997; 96: 3042-3047
8 Zhu YP. Chinese material medica: chemistry, pharmacology and applications. Amsterdam: Harwood Academic Publishers; 1998: 609-612
9 Yin S, Fan CQ, Wang Y, Dong L, Yue JM. Antibacterial prenylflavone derivatives from Psoralea corylifolia and their structure-activity relationship study. Biol Med Chem 2004; 12: 4387-4392
10 Lee MH, Kim JY, Ryu JH. Prenylflavones from Psoralea corylifolia inhibit nitric oxide synthase expression through the inhibition of IκBα degradation in activated microglial cells. Biol Pharm Bull 2005; 28: 2253-2257
11 Haraguchi H, Inoue J, Tamura Y, Mizutani K. Inhibition of mitochondrial lipid peroxidation by bakuchiol, a meroterpene from Psoralea corylifolia . Planta Med 2000; 66: 569-571
12 Kim YC, Oh H, Kim BS, Kang TH, Ko EK, Han YM, Kim BY, Ahn JS. In vitro protein tyrosine phosphatase 1B inhibitory phenols from the seeds of Psoralea corylifolia . Planta Med 2005; 71: 87-89
13 Park EJ, Zhao YZ, Kim YC, Sohn DH. Protective effect of (S)-bakuchiol from Psoralea corylifolia on rat liver injury in vitro and in vivo . Planta Med 2005; 71: 508-513
14 Choi JH, Rho MC, Lee SW, Choi JN, Kim K, Song GY, Kim YK. Bavachin and isobavachacone, acyl-coenzyme A: cholesterol acyltransferase inhibitors from Psoralea corylifolia . Arch Pharm Res 2008; 31: 1419-1423
15 Kim YJ, Lee H, Park E, Shim SH. Inhibition of human 20S proteasome by compounds from seeds of Psoralea corylifola . Bull Korean Chem Soc 2009; 30: 1867-1869
16 Li HC, Zhang GY. Inhibitory effect of genistein on activation of STAT3 induced by brain ischemia/reperfusion in rat hippocampus. Acta Pharmacol Sin 2003; 24: 1131-1136
17 Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, Milbrandt J, Pinsky D, Kisiel W, Stern D. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 1998; 95: 8298-8303